The interrelationships between Src, Cav-1 and RhoGD12 in transitional cell carcinoma of the bladder

British Journal of Cancer

Volumn 106, Issue 6, 2012, Pages 1187-1195

  Qayyum, T ^a   Fyffe, G ^a   Duncan, M ^a   McArdle, P A ^a   Hilmy, M ^b   Orange, C ^b   Halbert, G ^c   Seywright, M ^c   Horgan, P G ^a   Underwood, M A ^b   Edwards, J ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b GLASGOW ROYAL INFIRMARY   (United Kingdom)

^c WESTERN INFIRMARY   (United Kingdom)

Author keywords

bladder cancer; Cav 1; RhoGD12; Src kinase; survival

Indexed keywords

CAVEOLIN; FOCAL ADHESION KINASE; PROTEIN RHOGD12; PROTEIN TYROSINE KINASE; RHO FACTOR; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BLADDER CARCINOMA; CANCER SPECIFIC SURVIVAL; ENZYME PHOSPHORYLATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSITIONAL CELL CARCINOMA;

CARCINOMA, TRANSITIONAL CELL; CAVEOLIN 1; CELL MEMBRANE; CELL NUCLEUS; CYTOPLASM; ENZYME ACTIVATION; FOCAL ADHESION PROTEIN-TYROSINE KINASES; GENE EXPRESSION; GUANINE NUCLEOTIDE DISSOCIATION INHIBITORS; HUMANS; KAPLAN-MEIER ESTIMATE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM GRADING; PHOSPHORYLATION; PROGNOSIS; PROTEIN-TYROSINE KINASES; URINARY BLADDER NEOPLASMS;

EID: 84858297849     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2012.52     Document Type: Article

References (51)

1. Advanced Bladder Cancer (ABC) Meta-analysis Collaboration (2005) Neoadjuvant chemotherapy in invasive bladder cancer: update of a systematic review and meta-analysis of individual patient data advanced bladder cancer (ABC) meta-analysis collaboration. Eur Urol 48(2): 202-205
2. Blaveri E, Simko JP, Korkola JE, Brewer JL, Baehner F, Mehta K, Devries S, Koppie T, Pejavar S, Carroll P, Waldman FM (2005) Bladder cancer outcome and subtype classification by gene expression. Clin Cancer Res 11(11): 4044-4055 (Pubitemid 40791568)
3. Bolen JB, Veillette A, Schwartz AM, DeSeau V, Rosen N (1987) Activation of pp60c-src protein kinase activity in human colon carcinoma. Proc Natl Acad Sci USA 84(8): 2251-2255 (Pubitemid 17075849)
4. Calalb MB, Polte TR, Hanks SK (1995) Tyrosine phosphorylation of focal adhesion kinase at sites in the catalytic domain regulates kinase activity: a role for Src family kinases. Mol Cell Biol 15(2): 954-963
5. Calalb MB, Zhang X, Polte TR, Hanks SK (1996) Focal adhesion kinase tyrosine-861 is a major site of phosphorylation by Src. Biochem Biophys Res Commun 228(3): 662-668 (Pubitemid 26421437)
6. Campbell EJ, McDuff E, Tatarov O, Tovey S, Brunton V, Cooke TG, Edwards J (2008) Phosphorylated c-Src in the nucleus is associated with improved patient outcome in ER-positive breast cancer. Br J Cancer 99(11): 1769-1774
7. Cao H, Courchesne WE, Mastick CC (2002) A phosphotyrosine-dependent protein interaction screen reveals a role for phosphorylation of caveolin-1 on tyrosine 14: recruitment of C-terminal Src kinase. J Biol Chem277(11): 8771-8774 (Pubitemid 34952941)
8. Cho HJ, Baek KE, Park SM, Kim IK, Choi YL, Cho HJ, Nam IK, Hwang EM, Park JY, Han JY, Kang SS, Kim DC, Lee WS, Lee MN, Oh GT, Kim JW, Lee CW, Yoo J (2009) RhoGDI2 expression is associated with tumor growth and malignant progression of gastric cancer. Clin Cancer Res 15(8): 2612-2619
9. Cooper JA, Howell B (1993) The when and how of Src regulation. Cell 73(6): 1051-1054 (Pubitemid 23180479)
10. Dalbagni G, Genega E, Hashibe M, Zhang ZF, Russo P, Herr H, Reuter V (2001) Cystectomy for bladder cancer: a contemporary series. J Urol 165(4): 1111-1116 (Pubitemid 32210214)
11. Davidson B, Nesland JM, Goldberg I, Kopolovic J, Gotlieb WH, Bryne M, Ben-Baruch G, Berner A, Reich R (2001) Caveolin-1 expression in advanced-stage ovarian carcinoma-a clinicopathologic study. Gynecol Oncol 81(2): 166-171 (Pubitemid 32424155)
12. Elsberger B, Tan BA, Mitchell TJ, Brown SB, Mallon EA, Tovey SM, Cooke TG, Brunton VG, Edwards J (2009) Is expression or activation of Src kinase associated with cancer-specific survival in ER-, PR-and HER2-negative breast cancer patients? Am J Pathol 175(4): 1389-1397
13. Engen JR, Wales TE, Hochrein JM, Meyn III MA, Banu OS, Bahar I, Smithgall TE (2008) Structure and dynamic regulation of Src-family kinases. Cell Mol Life Sci 65(19): 3058-3073
14. Epstein JI, Amin MB, Reuter VR, Mostofi FK (1998) The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Bladder Consensus Conference Committee. Am J Surg Pathol 22(12): 1435-1448 (Pubitemid 28550639)
15. Fanning P, Bulovas K, Saini KS, Libertino JA, Joyce AD, Summerhayes IC (1992) Elevated expression of pp60c-src in low grade human bladder carcinoma. Cancer Res 52(6): 1457-1462
16. Fine SW, Lisanti MP, Galbiati F, Li M (2001) Elevated expression of caveolin-1 in adenocarcinoma of the colon. Am J Clin Pathol 115(5): 719-724 (Pubitemid 33051539)
17. Fong A, Garcia E, Gwynn L, Lisanti MP, Fazzari MJ, Li M (2003) Expression of caveolin-1 and caveolin-2 in urothelial carcinoma of the urinary bladder correlates with tumor grade and squamous differentiation. Am J Clin Pathol 120(1): 93-100 (Pubitemid 37046375)
18. Frame MC (2002) Src in cancer: deregulation and consequences for cell behaviour. Biochim Biophys Acta 1602(2): 114-130 (Pubitemid 34521791)
19. Galbiati F, Volonte D, Engelman JA, Watanabe G, Burk R, Pestell RG, Lisanti MP (1998) Targeted downregulation of caveolin-1 is sufficient to drive cell transformation and hyperactivate the p42/44 MAP kinase cascade. EMBO J 17(22): 6633-6648 (Pubitemid 28521797)
20. Galbiati F, Volonte D, Liu J, Capozza F, Frank PG, Zhu L, Pestell RG, Lisanti MP (2001) Caveolin-1 expression negatively regulates cell cycle progression by inducing G(0)/G(1) arrest via a p53/p21(WAF1/Cip1)-dependent mechanism. Mol Biol Cell 12(8): 2229-2244 (Pubitemid 33051953)
21. Gildea JJ, Seraj MJ, Oxford G, Harding MA, Hampton GM, Moskaluk CA, Frierson HF, Conaway MR, Theodorescu D (2002) RhoGDI2 is an invasion and metastasis suppressor gene in human cancer. Cancer Res 62(22): 6418-6423 (Pubitemid 35364098)
22. Glenney Jr JR, Zokas L (1989) Novel tyrosine kinase substrates from Rous sarcoma virus-transformed cells are present in the membrane skeleton. J Cell Biol 108(6): 2401-2408 (Pubitemid 19168929)
23. Grande-Garcia A, Echarri A, de RJ, Alderson NB, Waterman-Storer CM, Valdivielso JM, del Pozo MA (2007) Caveolin-1 regulates cell polarization and directional migration through Src kinase and Rho GTPases. J Cell Biol 177(4): 683-694 (Pubitemid 46799839)
24. Ho CC, Huang PH, Huang HY, Chen YH, Yang PC, Hsu SM (2002) Up-regulated caveolin-1 accentuates the metastasis capability of lung adenocarcinoma by inducing filopodia formation. Am J Pathol 161(5): 1647-1656
25. Ito Y, Yoshida H, Nakano K, Kobayashi K, Yokozawa T, Hirai K, Matsuzuka F, Matsuura N, Kakudo K, Kuma K, Miyauchi A (2002) Caveolin-1 overexpression is an early event in the progression of papillary carcinoma of the thyroid. Br J Cancer 86(6): 912-916 (Pubitemid 34271027)
26. Kirkegaard T, Edwards J, Tovey S, McGlynn LM, Krishna SN, Mukherjee R, Tam L, Munro AF, Dunne B, Bartlett JM (2006) Observer variation in immunohistochemical analysis of protein expression, time for a change? Histopathology 48(7): 787-794 (Pubitemid 43800937)
27. Kopetz S, Shah AN, Gallick GE (2007) Src continues aging: current and future clinical directions. Clin Cancer Res 13(24): 7232-7236
28. Kunze E, Von BF, Werner C, Wendt M, Schlott T (2006) Transitional cell carcinomas and nonurothelial carcinomas of the urinary bladder differ in the promoter methylation status of the caveolin-1, hDAB2IP and p53 genes, but not in the global methylation of Alu elements. Int J Mol Med 17(1): 3-13
29. Lee H, Volonte D, Galbiati F, Iyengar P, Lublin DM, Bregman DB, Wilson MT, Campos-Gonzalez R, Bouzahzah B, Pestell RG, Scherer PE, Lisanti MP (2000) Constitutive and growth factor-regulated phosphorylation of caveolin-1 occurs at the same site (Tyr-14) in vivo: identification of a c-Src/Cav-1/Grb7 signaling cassette. Mol Endocrinol 14(11): 1750-1775
30. Li S, Couet J, Lisanti MP (1996) Src tyrosine kinases, Galpha subunits, and H-Ras share a common membrane-anchored scaffolding protein, caveolin. Caveolin binding negatively regulates the auto-activation of Src tyrosine kinases. J Biol Chem 271(46): 29182-29190 (Pubitemid 26382628)
31. Liu P, Rudick M, Anderson RG (2002) Multiple functions of caveolin-1. J Biol Chem 277(44): 41295-41298 (Pubitemid 35257426)
32. Luo FR, Barrett YC, Yang Z, Camuso A, McGlinchey K, Wen ML, Smykla R, Fager K, Wild R, Palme H, Galbraith S, Blackwood-Chirchir A, Lee FY (2008) Identification and validation of phospho-SRC, a novel and potential pharmacodynamic biomarker for dasatinib (SPRYCEL), a multi-targeted kinase inhibitor. Cancer Chemother Pharmacol 62(6): 1065-1074
33. Masaki T, Okada M, Shiratori Y, Rengifo W, Matsumoto K, Maeda S, Kato N, Kanai F, Komatsu Y, Nishioka M, Omata M (1998) pp60c-src activation in hepatocellular carcinoma of humans and LEC rats. Hepatology 27(5): 1257-1264 (Pubitemid 28227852)
34. Moon HG, Jeong SH, Ju YT, Jeong CY, Lee JS, Lee YJ, Hong SC, Choi SK, Ha WS, Park ST, Jung EJ (2010) Up-regulation of RhoGDI2 in human breast cancer and its prognostic implications. Cancer Res Treat 42(3): 151-156
35. Nam S, Kim D, Cheng JQ, Zhang S, Lee JH, Buettner R, Mirosevich J, Lee FY, Jove R (2005) Action of the Src family kinase inhibitor, dasatinib (BMS-354825), on human prostate cancer cells. Cancer Res 65(20): 9185-9189 (Pubitemid 41507982)
36. Niu H, Li H, Xu C, He P (2010) Expression profile of RhoGDI2 in lung cancers and role of RhoGDI2 in lung cancer metastasis. Oncol Rep 24(2): 465-471
37. Rajjayabun PH, Garg S, Durkan GC, Charlton R, Robinson MC, Mellon JK (2001) Caveolin-1 expression is associated with high-grade bladder cancer. Urology 58(5): 811-814
38. Sanchez-Carbayo M, Socci ND, Lozano J, Saint F, Cordon-Cardo C (2006) Defining molecular profiles of poor outcome in patients with invasive bladder cancer using oligonucleotide microarrays. J Clin Oncol 24(5): 778-789 (Pubitemid 46622045)
39. Schaller MD, Hildebrand JD, Shannon JD, Fox JW, Vines RR, Parsons JT (1994) Autophosphorylation of the focal adhesion kinase, pp125FAK, directs SH2-dependent binding of pp60src. Mol Cell Biol 14(3): 1680-1688
40. Slack NH, Bross ID, Prout Jr GR (1977) Five-year follow-up results of a collaborative study of therapies for carcinoma of the bladder. J Surg Oncol 9(4): 393-405 (Pubitemid 8162128)
41. Smith Jr JA, Crawford ED, Paradelo JC, Blumenstein B, Herschman BR, Grossman HB, Christie DW (1997) Treatment of advanced bladder cancer with combined preoperative irradiation and radical cystectomy vs radical cystectomy alone: a phase III intergroup study. J Urol 157(3): 805-807
42. Stein JP, Lieskovsky G, Cote R, Groshen S, Feng AC, Boyd S, Skinner E, Bochner B, Thangathurai D, Mikhail M, Raghavan D, Skinner DG (2001) Radical cystectomy in the treatment of invasive bladder cancer: longterm results in 1,054 patients. J Clin Oncol 19(3): 666-675 (Pubitemid 32120143)
43. Stein JP, Skinner DG (2006) Radical cystectomy for invasive bladder cancer: long-term results of a standard procedure. World J Urol 24(3): 296-304 (Pubitemid 44143761)
44. Sylvester RJ, van der Meijden AP, Oosterlinck W, Witjes JA, Bouffioux C, Denis L, Newling DW, Kurth K (2006) Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials. Eur Urol 49(3): 466-465
45. Tapper J, Kettunen E, El-Rifai W, Seppala M, Andersson LC, Knuutila S (2001) Changes in gene expression during progression of ovarian carcinoma. Cancer Genet Cytogenet 128(1): 1-6 (Pubitemid 32655473)
46. Tatarov O, Mitchell TJ, Seywright M, Leung HY, Brunton VG, Edwards J (2009) SRC family kinase activity is up-regulated in hormone-refractory prostate cancer. Clin Cancer Res 15(10): 3540-3549
47. Theodorescu D, Sapinoso LM, Conaway MR, Oxford G, Hampton GM, Frierson Jr HF (2004) Reduced expression of metastasis suppressor RhoGDI2 is associated with decreased survival for patients with bladder cancer. Clin Cancer Res 10(11): 3800-3806 (Pubitemid 38697615)
48. Thomas S, Overdevest JB, Nitz MD, Williams PD, Owens CR, Sanchez-Carbayo M, Frierson HF, Schwartz MA, Theodorescu D (2011) Src and caveolin-1 reciprocally regulate metastasis via a common downstream signaling pathway in bladder cancer. Cancer Res 71(3): 832-841
49. Volonte D, Zhang K, Lisanti MP, Galbiati F (2002) Expression of caveolin-1 induces premature cellular senescence in primary cultures of murine fibroblasts. Mol Biol Cell 13(7): 2502-2517
50. Wu Y, Moissoglu K, Wang H, Wang X, Frierson HF, Schwartz MA, Theodorescu D (2009) Src phosphorylation of RhoGDI2 regulates its metastasis suppressor function. Proc Natl Acad Sci USA 106(14): 5807-5812
51. Zhang Y, Zhang B (2006) D4-GDI, a Rho GTPase regulator, promotes breast cancer cell invasiveness. Cancer Res 66(11): 5592-5598 (Pubitemid 43927109)